403 Revenue and Competitors
Estimated Revenue & Valuation
- 403's estimated annual revenue is currently $1.6M per year.
- 403's estimated revenue per employee is $155,000
Employee Data
- 403 has 10 Employees.
- 403 grew their employee count by 0% last year.
403's People
Name | Title | Email/Phone |
---|---|---|
1 | Senior Customer Service Representative | Reveal Email/Phone |
2 | Laboratory Accessioner | Reveal Email/Phone |
403 Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.8M | 5 | -17% | N/A | N/A |
#2 | $5.7M | 37 | 6% | N/A | N/A |
#3 | $10.2M | 66 | 6% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.6M | 49 | -2% | N/A | N/A |
#7 | $0.8M | 5 | -17% | N/A | N/A |
#8 | $7.9M | 51 | 6% | N/A | N/A |
#9 | $37.7M | 243 | -2% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is 403?
Strand Diagnostics, privately owned and located in Indianapolis, Indiana, was formed as a forensic DNA testing crime lab in 2005 and still maintains its FBI-accreditation and processes crime-scene samples for a number of public police agencies throughout the United States. Strand Diagnostics developed and markets the know error® system, which utilizes bar coding, forensic principles and DNA matching to confirm that surgical biopsy samples being evaluated belong exclusively to the patient being diagnosed. Since 2008, Strand Diagnostics has maintained its CLIA accreditation and has processed prostate and breast biopsy collections samples from over 300,000 patients. Visit www.knowerror.com and www.stranddiagnostics.com.
keywords:N/AN/A
Total Funding
10
Number of Employees
$1.6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.9M | 10 | 11% | N/A |
#2 | $0.9M | 10 | 0% | N/A |
#3 | $0.9M | 10 | 0% | N/A |
#4 | N/A | 10 | -62% | N/A |
#5 | $1M | 10 | -66% | N/A |